UTHealth Houston Study on Repeated Radiofrequency Ablation in Combination With Chemotherapy for Pancreatic Cancer Supported With $3.3M HHS Grant
June 17, 2023
June 17, 2023
HOUSTON, Texas, June 17 (TNSfund) -- The University of Texas Health Science Center at Houston issued the following news:
A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.
The survival rate of pancreatic adenocarcinoma, or pancreatic cancer, r . . .
A combination strategy of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) with chemotherapy for pancreatic cancer will be studied at UTHealth Houston through a $3.3 million grant from the National Cancer Institute by the U.S. Department of Health and Human Services.
The survival rate of pancreatic adenocarcinoma, or pancreatic cancer, r . . .